Загрузка...
B cells as a therapeutic target in autoimmune disease
Depleting B cells with anti-CD20 monoclonal antibodies emerges as a new therapeutic strategy in autoimmune diseases. Preliminary clinical studies suggest therapeutic benefits in patients with classic autoantibody-mediated syndromes, such as autoimmune cytopenias. Treatment responses in rheumatoid ar...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2003
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC165047/ https://ncbi.nlm.nih.gov/pubmed/12723978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar751 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|